ABOUT US

Yunnan Hanmeng Pharmaceutical Co., Ltd. was established in October 2017 and is a holding enterprise of China's state-owned listed company, Chengzhi Co., Ltd. (stock code: 000990). Chengzhi Hanmeng strictly designs and constructs a natural plant extraction and processing factory in accordance with international drug GMP standards and BRC system, with a construction area of 60000 square meters and an annual processing capacity of 3000 tons of natural plants. The independently developed intelligent manufacturing management system (MES) and intelligent warehouse management system (WMS) can achieve a controllable and traceable full chain from raw material planting, harvesting and storage, to product production and finished product inspection and release, ensuring the cleanliness of raw materials Product safety, providing the public with a range of high-quality and reliable cannabis products, making it the world's most powerful and technologically advanced cannabis processing enterprise.

Breeding and planting

The breeding and planting research work of Chengzhi Hanmeng mainly includes seed research and development, seed selection, and large-scale planting. In the future, we plan to carry out 2000 acres of field planting every year, adopting a planting development model of company+base+farmers, focusing on improving hemp yield and CBD content. Planting marijuana in the tropical high-altitude Yunnan Plateau north of the equator (with an average altitude of 2200 meters), where there is ample sunshine, abundant precipitation, and a large temperature difference between day and night, the unique climate of the plateau provides an excellent growth environment for marijuana; Far away from the city, with a radius of 100 miles without pollution, truly achieving the original ecology of raw materials and zero pollution of products.

About UsINDUSTRIAL LAYOUT

The industrial layout of Chengzhi Hanmeng covers all aspects of breeding and planting, processing and extraction, research and development, and production and sales. Two research centers have been established, responsible for basic application research and development, and technology achievement development and transformation, respectively, to cultivate CBD high-content varieties with high stability, high stress resistance, good yield, and suitable for large-scale planting; Mastered industrial extraction processes for various high-quality cannabinoids and non cannabinoid compounds, ensuring product consistency and stability; Develop a variety of industrial cannabis consumer products, including pharmaceuticals, dietary supplements, functional foods, topical products, etc., forming an industrial layout that combines upstream, midstream, and downstream industries and short, medium, and long-term products to meet the needs of different consumers.